Augmentation of antitumor effect of recombinant interleukin-2 activated killer cells by the administration of rIL-2 and lentinan.
Shimizu
H
H
Department of Obstetrics and Gynecology, Osaka University Medical School.
Inoue
M
M
Shimizu
C
C
Saito
J
J
Ueda
G
G
Tanizawa
O
O
D000818:Animals; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D007912:Lentinan / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D011134:Polysaccharides / Q000494:pharmacology*; D011994:Recombinant Proteins; D014183:Transplantation, Heterologous; D014594:Uterine Neoplasms / Q000276:immunology / Q000628:therapy*
D007376:Interleukin-2; D011134:Polysaccharides; D011994:Recombinant Proteins; D007912:Lentinan